文献速递临床试验与 GCP

瑞芬太尼-丙泊酚联合右美托咪定对老年输尿管镜钬激光碎石术后认知功能障碍的影响:一项双盲随机对照试验

The effects of remifentanil-propofol combined with dexmedetomidine on cognitive dysfunction in elderly patients after ureteroscopic holmium laser lithotripsy: a double-blind randomized controlled trial.
PubMed 文献 · Trials · 2022-03-03

该双盲随机对照试验纳入120例拟行输尿管镜钬激光碎石的老年患者,随机分为PR组(生理盐水)和PRD组(右美托咪定0.4 μg kg-1 h-1,麻醉诱导后静脉输注,手术结束前30 min停止)。主要结局为简易精神状态检查评分。结论:右美托咪定对术后认知功能障碍无影响,但可减少瑞芬太尼和丙泊酚用量,并降低术后躁动、焦虑和抑郁的发生率及严重程度。

要点

  • 右美托咪定对老年患者术后认知功能障碍无影响。
  • 右美托咪定可减少术中瑞芬太尼和丙泊酚的用量。
  • 右美托咪定降低术后躁动、焦虑和抑郁的发生率及严重程度。

核心结论

  • 右美托咪定给药对术后认知功能障碍无影响,但可减少输尿管镜钬激光碎石术中瑞芬太尼和丙泊酚的用量,并降低老年患者术后躁动、焦虑和抑郁的发生率及严重程度。

研究设计与样本

  • 双盲随机对照试验,共纳入120例拟行输尿管镜钬激光碎石的老年患者,随机分为PR组(给予生理盐水)和PRD组(麻醉诱导后静脉给予右美托咪定0.4 μg kg-1 h-1,手术结束前30 min停止)。

主要发现

  • 两组MMSE评分在T1-2时均降低(P < 0.001)。
  • PRD组丙泊酚和瑞芬太尼用量较PR组显著减少(P < 0.001)。
  • PRD组在t1-3时RASS评分和躁动(EA)发生率均显著低于PR组(P < 0.001)。
  • 与PR组相比,PRD组在T1-2时ZSDS评分和STAI评分较低(P < 0.005)。
  • PR组在T2时准确回忆的阿拉伯数字个数低于PRD组(P < 0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A clinical study indicated that infusion of dexmedetomidine without a loading dose administered intraoperatively provided a smooth and hemodynamically stable emergence and improved the quality of recovery with fewer postoperative side effects and reduced analgesic requirements. The objective was to determine whether administering remifentanil-propofol combined with dexmedetomidine during general anesthesia would decrease the incidence and severity of postoperative emergence agitation, anxiety, and depression without affecting cognitive dysfunction in elderly patients. METHODS: A total of 120 elderly patients scheduled for ureteroscopic holmium laser lithotripsy were randomly allocated to the PR group and administered normal saline, and the PRD group was administered dexmedetomidine 0.4 μg kg-1 h-1 intravenously after the induction of anesthesia and stopped 30 min before the end of surgery. The primary outcome was the Mini-Mental State Examination score. The secondary outcomes were the Richmond Agitation Sedation, the State-Trait Anxiety Inventory, and the Zung Self-Rating Depression Scale scores; the memory span for Arabic numerals; the duration of surgery; and the time to spontaneous respiration, recovery, and extubation. RESULTS: The MMSE scores were lower at T1-2 in the two groups (P < 0.001). The dosage of propofol and remifentanil decreased more significantly in the PRD group than in the PR group (P < 0.001). Both the RASS scores and the incidence of emergence agitation (EA) in the PRD group were significantly lower than those in the PR group at t1-3 (P < 0.001). Compared to the PR group, the ZSDS scores and STAI scores at T1-2 were lower in the PRD group (P < 0.005). The number of the Arabic numbers that were accurately recalled from memory was lower at T2 in the PR group than in the PRD group (P < 0.001). CONCLUSION: Dexmedetomidine administration has no influence on postoperative cognitive dysfunction but could reduce both the dosage of remifentanil and propofol needed during ureteroscopic holmium laser lithotripsy and the incidence and severity of postoperative emergence agitation, anxiety, and depression in elderly patients. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR1900021254 . Registered on 3 February 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang F, Xie D, Xu H, et al. The effects of remifentanil-propofol combined with dexmedetomidine on cognitive dysfunction in elderly patients after ureteroscopic holmium laser lithotripsy: a double-blind randomized controlled trial. Trials. 2022. PMID: 35241145. doi:10.1186/s13063-022-06121-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。